SANOFI – Group report and key figures

WHAT IS THE GROUP'S FINANCIAL SITUATION ?

The financial indicators presented in this report include: consolidated revenue, consolidated EBIT and EBIT ratio, consolidated net profit and net profit rate, R&D expenditure and ratio, sales by segment and by region, profitability, liquidity and solvency ratios, free cash flow and capital expenditure.

WHAT ARE THE GROUP'S STRATEGIC PRIORITIES ?

Drive growth through organic innovation

Expand treatment portfolio through external measures

Reduce operating costs

WHAT ARE THE GROUP'S STRENGTHS AND WEAKNESSES ?

Through a SWOT analysis, this report also provides an overview of the group's strengths (significant cash pile to fund growth and acquisitions over the coming years, etc.) and weaknesses (blockbuster treatments facing patent cliff and generics competition, etc.).

1. Overview

Presentation

Segments

SWOT

2. Corporate Strategies and Recent Events

3. Financial Indicators

4. Statistical Appendix

5. Glossary